Literature DB >> 10694729

Sample size considerations for the evaluation of prognostic factors in survival analysis.

C Schmoor1, W Sauerbrei, M Schumacher.   

Abstract

When the role of a new prognostic factor is investigated, careful planning of an appropriate study is required. This includes an assessment of the power of the study in terms of sample sizes. An adequate analysis of the independent prognostic effect of a new factor has to be adjusted for the existing standard factors. With survival time as endpoint this will usually be done with the Cox proportional hazards model. Sample size and power formulae in survival analysis have been developed by Schoenfeld for randomized treatment comparisons. In the analysis of prognostic factors the covariates included are expected to be correlated with the factor of primary interest. In this situation, the existing sample size and power formulae are not valid and may not be applied. In this paper, Schoenfeld's formula is first extended to the situation where a correlated factor is included in the analysis. The validity of the resulting approximate asymptotic formula is investigated for its asymptotic behaviour by numerical integration and for its finite behaviour by simulation. Second, an approximate formula for sample size and power is provided to detect an interaction between the interesting and a second correlated factor. This extends the formula for independent effects. Finally, the approach is illustrated by an example on the prognostic impact of DNA ploidy and other factors in advanced ovarian cancer. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694729     DOI: 10.1002/(sici)1097-0258(20000229)19:4<441::aid-sim349>3.0.co;2-n

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  28 in total

Review 1.  Risk factors for sports injuries--a methodological approach.

Authors:  R Bahr; I Holme
Journal:  Br J Sports Med       Date:  2003       Impact factor: 13.800

2.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

3.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

4.  Design and Rationale of a Randomized Trial of a Care Transition Strategy in Patients With Acute Heart Failure Discharged From the Emergency Department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients With Heart Failure).

Authors:  Gregory J Fermann; Phillip D Levy; Peter Pang; Javed Butler; S Imran Ayaz; Douglas Char; Patrick Dunn; Cathy A Jenkins; Christy Kampe; Yosef Khan; Vijaya A Kumar; JoAnn Lindenfeld; Dandan Liu; Karen Miller; W Frank Peacock; Samaa Rizk; Chad Robichaux; Russell L Rothman; Jon Schrock; Adam Singer; Sarah A Sterling; Alan B Storrow; Cheryl Walsh; John Wilburn; Sean P Collins
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

5.  A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer.

Authors:  Silvia Dellapasqua; Vincenzo Bagnardi; Meredith M Regan; Nicole Rotmensz; Mauro G Mastropasqua; Giuseppe Viale; Eugenio Maiorano; Karen N Price; Richard D Gelber; Monica Castiglione-Gertsch; Aron Goldhirsch; Marco Colleoni
Journal:  Breast       Date:  2012-06-29       Impact factor: 4.380

6.  Precision oncology for acute myeloid leukemia using a knowledge bank approach.

Authors:  Moritz Gerstung; Elli Papaemmanuil; Inigo Martincorena; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Michael Heuser; Felicitas Thol; Niccolo Bolli; Peter Ganly; Arnold Ganser; Ultan McDermott; Konstanze Döhner; Richard F Schlenk; Hartmut Döhner; Peter J Campbell
Journal:  Nat Genet       Date:  2017-01-16       Impact factor: 38.330

Review 7.  [Value of biomarkers in urology].

Authors:  P J Goebell; B Keck; S Wach; B Wullich
Journal:  Urologe A       Date:  2010-04       Impact factor: 0.639

8.  Previous injury as a risk factor for injury in elite football: a prospective study over two consecutive seasons.

Authors:  M Hägglund; M Waldén; J Ekstrand
Journal:  Br J Sports Med       Date:  2006-07-19       Impact factor: 13.800

Review 9.  The importance of identifying and validating prognostic factors in oncology.

Authors:  Susan Halabi; Kouros Owzar
Journal:  Semin Oncol       Date:  2010-04       Impact factor: 4.929

10.  Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.

Authors:  Mary A Whooley; Peter de Jonge; Eric Vittinghoff; Christian Otte; Rudolf Moos; Robert M Carney; Sadia Ali; Sunaina Dowray; Beeya Na; Mitchell D Feldman; Nelson B Schiller; Warren S Browner
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.